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We have examined a series of 37 patients
with histologically proved primary malignant
melanoma for evidence of tumour-directed
cellular immunity. Using the leucocyte
migration technique we found evidence of
such reactivity in 24/37 patients. Tests
with control donors' leucocytes and control
antigen preparations supported the specificity
of the reaction. The histology of all
tumours was carefully analysed using new
criteria (Classification of Melanoma, Sydney
1972. Cancer, N.Y., 1972 [in press]) for
histological analysis of malignant melanoma.
Histological and immunological findings for
each patient were collated. Evidence of
immune reactivity was most frequently
associated with superficial tumours; tumours
showing microscopic evidence of lymphatic
invasion, non-ulcerated tumours showing a
heavy peritumoral infiltrate of lymphocytes
and plasma cells.
FLUORESCENT ANTIBODY STUDIES
IN MALIGNANT MELANOMA. R. H.
WHITEHEAD and L. E. HUGHES. University
Department of Surgery, Welsh National
School ofMedicine, Cardiff.
There have been a number of reports
describing antibody to melanoma in approxi-
mately 60% of patients with melanoma.
However, the technique and the site of
fluorescence within the cell have varied.
Sera from melanoma patients were tested
against 6 melanoma cell lines by immuno-
fluorescence using cell smears. Results were
analysed with regard to the pathological
classification of the patients' tumour. No
immunofluorescence was detected with sera
from patients presenting with tumour re-
stricted to the upper dermis, whereas up to
40% of patients wth tumour spread to the
lower dermis were positive. Sera from
patients with secondary melanoma showed a
higher reactivity.
The cell lines varied in antigenicity and
the lines which were most antigenic were also
most reactive against normal sera.
Ifthe results were analysed with regard to
the number of sera reacting against at least
one cell line, then 50% ofprimary melanoma
sera and 90% of secondary melanoma sera
were positive.
This indicates that the method ofanalysis
is crucial to the final result, and the current
status of serum immunity to melanoma is
discussed in this context.
ASSESSMENT OF LYMPHOCYTE
TRANSFORMATION IN THE
PATIENT PRESENTING WITH
HODGKIN'S DISEASE. P. M. DENTON
and E. M. STANLEY. Radiotherapy Re-
search Unit, Royal Marsden Hospital, Sutton.
Surrey.
There has been much discussion as to
whether Hodgkin's disease reflects a state of
impaired lymphocyte function. That the
disease seems to be characterized by the early
onset of immunological derangement with
regard to cell mediated immunity gives some
support to this tenet. Recently, however,
the percentage of Hodgkin's disease patients
showing early anergy has been questioned.
A closer look at the lymphocytes in Hodgkin's
disease and their ability to initiate an
immune response seemed to be indicated.
A longitudinal study has commenced to
investigate the variable ability of peripheral
blood lymphocytes from Hodgkin's disease
patients to transform, under stimulation by
the one-way mixed lymphocyte reaction,
from the time of presentation through the
course of their disease.
Preliminary observations indicate that
the degree of lymphocyte transformation in
the untreated Hodgkin's disease patient does
not show any correlation with the age, sex,
clinical stage, histology or presence of
systemic symptoms. The degree of stimula-
tion has been found to be independent of the
absolute lymphocyte count.
Commencement of radiotherapy abolishes
lymphocyte transformation and its effects
are prolonged. The effect of chemotherapy
is less severe.
LYMPHOCYTE TRANSFORMATION
IN LARGE BOWEL CANCER. I.
LAUDER. Department of Pathology, Royal
Victoria Infirmary, Newcastle upon Tyne,
and G. BONE, Department of Surgery,
University ofNewcastle upon Tyne.
Controversy still exists as to whether
lymphocyte transformation to phytohaemag-
glutinin (PHA) is depressed in patients with
non-lymphoid malignancies. The need to
determine dose response curves in any patient
with suspected immune deficiency hasABSTRACTS OF MEMBERS PROFFERED PAPERS 79
recently been stressed (Fitzgerald, ClGn. exp.
Immunol., 1971, 8, 421). Twenty-one
patients and the same number of age-
matched controls were studied. Lympho-
cyte transformation was induced at seven
concentrations of PHA and the response
measured by the incorporation of [14C]-
thymidine. Using the data obtained, dose
response curves were plotted for both the
cancer and control patients. A statistically
highly significant difference between the two
groups emerged at three different concentra-
tions. This was considered to reflect a
depression in " T " lymphocyte function but
it was not possible to say whether this was
due to a deficiency in the cells themselves or
due to a serum inhibitory factor.
INHIBITION OF CELL MEDIATED
CYTOTOXICITY AGAINST HUMAN
COLON CARCINOMATA BY PAPAIN-
SOLUBILIZED TUMOUR MEMBRANE
EXTRACTS. M. J. EMBLETON and M. R.
PRICE. Cancer Research Campaign Labora-
tories, University of Nottingham.
Studies were undertaken to determine
whether soluble tumour antigen preparations
can infiuence cytotoxicity against cultured
colon carcinoma cells by lymphocytes from
colon carcinoma patients.
Peripheral lymphocytes from 61% of
tumour bearing or post-operative patients
were cytotoxic for colon carcinoma cells
compared with normal control lymphocytes,
as assayed by their capacity to reduce the
survival of target cells in microtitration
plates. Papain-solubilized membrane ex-
tracts were prepared from pooled colon
carcinomata, normal colon and melanoma,
and their effect on cell mediated cytotoxicity
was measured by incubation with patients'
and control lymphocytes before addition of
the lymphocytes to target cells. Colon
carcinoma extracts inhibited cytotoxicity
but normal colon or melanoma extracts had
no effect. The inhibition of lymphocyte
reactivity by soluble antigen may have
important implications regarding the possible
modification of tumour-immune reactions
in vivo by circulating tumour antigen.
BCG IMMUNOTHERAPY OF RAT
SARCOMATA. R. W. BALDWIN and M. V.
PIMM. Cancer Research Campaign Labora-
tories, University of Nottingham.
Growth of immunogenic 3-methylchol-
anthrene induced rat sarcomata was suppres-
sed if tumour cells were transplanted sub-
cutaneously in admixture with as little as
10 ,ug of viable BCG. Animals rejecting
sarcoma cell-BCG inocula were subsequently
immune to challenge with the same tumour,
indicating the involvement of host responses
to tumour associated rejection antigens.
Furthermore, rejection of mixed inocula
suppressed growth of a simultaneous chal-
lenge of the same sarcoma at another site.
This specific active immunotherapy was
successful even if given after tumour
challenge.
Pulmonary growth ofintravenously trans-
ferred sarcoma cells was also controlled by
this form of active immunotherapy. More
effective control was obtained by intra-
venous administration of BCG alone, even if
delayed up to 7 days after challenge, perhaps
reflecting preferential pulmonary survival of
BCG and direct contact with tumour cells at
this site.
THE ROLE OF MACROPHAGES IN
CLASSIC MAREK'S DISEASE. J. C.
CAMPBELL. Cancer Research Campaign
Unit, Department of Veterinary Pathology,
Bush House, Milton Bridge, Midlothian.
Marek's disease is a contagious lympho-
proliferative condition of chickens caused by
a herpesvirus Type B and exhibits neural
and visceral forms. Cells involved are
mainly lymphocytes and plasmacytes.
Lesions may terminate as lymphomata.
Indirect and direct immunofluorescence
of cryostat sections and serosal spreads show
antigen mainly confined to histiocytes,
though vascular endothelium and neurilemma
are frequently positive and lymphoid foci
occasionally so. Fresh buffy coat prepara-
tions show positively staining monocytes
which metamorphose in culture to motile
macrophages. Lymphocytes adhere to
these, forming conspicuous immunofluores-
cent clusters. Intercellular bridging be-
tween macrophages leads to the formation of
immunofluorescent-positive polykaryocytes.
Lymphocytes containing macrophage-en-
dowed viral genome respond to the blasto-
genic effect of phytohaemagglutinin in vitro
and naked nucleoplasmic virions appear
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